We are a multidisciplinary team focused on improving the lives of cancer patients
We combine approaches from biology, engineering, neuroscience, and drug delivery to design novel cancer diagnostics and therapeutics
Check out our recent feature in the Eshelman Institute for Innovation Featured News about our novel diagnostic platform using brain slices, pioneered by Dr. Andrew Satterlee and our brain slice team members!
What we do:
Developing novel ex vivo tumor models using live animal tissue
Enhancing neural stem cells as anti-cancer therapeutics
Optimizing the delivery of cell therapies using biomaterial matrices
